# FDA Inspection 1111054 - Qilu Pharmaceutical (Hainan) Co. Ltd. - November 06, 2019

Source: https://www.globalkeysolutions.net/records/fda_inspections/qilu-pharmaceutical-hainan-co-ltd/82214876-7e78-4952-b51e-a5128b2e1651
Source feed: FDA_Inspections

> FDA Inspection 1111054 for Qilu Pharmaceutical (Hainan) Co. Ltd. on November 06, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1111054
- Company Name: Qilu Pharmaceutical (Hainan) Co. Ltd.
- Inspection Date: 2019-11-06
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1281926 - 2025-08-22](https://www.globalkeysolutions.net/records/fda_inspections/qilu-pharmaceutical-hainan-co-ltd/767c8add-29d3-4bb2-aa95-0b733a0ece90)
- [FDA Inspection 1209088 - 2023-05-19](https://www.globalkeysolutions.net/records/fda_inspections/qilu-pharmaceutical-hainan-co-ltd/6e8bd43e-ed93-47e5-874e-e0800b7e48d1)
- [FDA Inspection 1036684 - 2017-11-17](https://www.globalkeysolutions.net/records/fda_inspections/qilu-pharmaceutical-hainan-co-ltd/9b1c4308-e142-43a9-a008-cdbde2713b04)
- [FDA Inspection 984197 - 2016-08-02](https://www.globalkeysolutions.net/records/fda_inspections/qilu-pharmaceutical-hainan-co-ltd/477d4004-1a39-469d-99c5-b38be9e61a76)
- [FDA Inspection 880306 - 2014-05-23](https://www.globalkeysolutions.net/records/fda_inspections/qilu-pharmaceutical-hainan-co-ltd/f1601eb0-93ee-46e7-a66f-1f0cc41a8bd0)

Company: https://www.globalkeysolutions.net/companies/qilu-pharmaceutical-hainan-co-ltd/60dedaab-e32c-493a-894b-9eec7372c066

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c